Literature DB >> 15044401

Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.

S Taponen1, S Ahonkallio, H Martikainen, R Koivunen, A Ruokonen, U Sovio, A-L Hartikainen, A Pouta, J Laitinen, V King, S Franks, M I McCarthy, M-R Järvelin.   

Abstract

BACKGROUND: The aim of this study was to investigate the prevalence of polycystic ovaries (PCO) among women with self-reported oligomenorrhoea and/or hirsutism and to see whether women with symptoms and PCO have less favourable levels of biochemical markers than controls or women with symptoms and normal ovaries.
METHODS: The ultrasonographic ovarian morphology and the hormonal and metabolic profile of female cases with self-reported symptoms typical of polycystic ovary syndrome (PCOS) (n = 196) and asymptomatic controls (n = 67) at the age of 31 years were examined in a general population-based Northern Finland Birth Cohort 1966.
RESULTS: The prevalence of PCO (37.3 versus 18.2%; P = 0.004) was significantly higher in the cases (oligomenorrhoea and/or hirsutism) than in the controls. PCO morphology was detected in 18.4% of those who reported only hirsutism, in 47.9% of those reporting only oligomenorrhoea, and in 70.4% of those reporting both symptoms. In the cases with PCO compared to (i) the controls and (ii) the cases without PCO, body mass index (P = 0.026 and P = 0.011), ovarian volume [right P = 0.001, left P = 0.208 (non-significant) and right P < 0.001, left P = 0.022], mean follicle number (P < 0.001 and P < 0.001), testosterone (P = 0.063 and P = 0.029), free androgen index (P = 0.007 and P = 0.013) and insulin (P = 0.033 and P = 0.040) were higher, and sex hormone-binding globulin (P = 0.039 and P = 0.068) and glucose:insulin ratio (P = 0.060 and P = 0.054) lower. Cases with PCO also had higher waist:hip ratio (P = 0.011), infertility rate (P = 0.005) and glucose (P = 0.045) and lower insulin-like growth factor-binding protein-1 (P = 0.012) than controls. The clinical, hormonal and metabolic characteristics did not differ significantly between cases without PCO and controls with the exception of infertility rate, which was significantly higher in the cases without PCO (26.4 vs. 10.0%; P = 0.009).
CONCLUSIONS: In a general population, women with symptoms of oligomenorrhoea and/or hirsutism more often have PCO than asymptomatic women. Levels of biochemical and clinical markers in symptomatic women with PCO differed from and were less favourable than those in symptomatic women without PCO or asymptomatic women, implying an increased risk for health.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044401     DOI: 10.1093/humrep/deh214

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  27 in total

1.  Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Richard S Legro; Paulina A Essah; Teimuraz Apridonidze; Andrea Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

2.  Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure.

Authors:  E S Barrett; K M Hoeger; S Sathyanarayana; D H Abbott; J B Redmon; R H N Nguyen; S H Swan
Journal:  J Dev Orig Health Dis       Date:  2018-01-09       Impact factor: 2.401

Review 3.  New perspectives on the definition and management of polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2018-01-23       Impact factor: 4.256

4.  Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the Childhood Determinants of Adult Health Study and the Bogalusa Heart Study.

Authors:  Y He; J Tian; L Blizzard; W H Oddy; T Dwyer; L A Bazzano; M Hickey; E W Harville; A J Venn
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

5.  Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease.

Authors:  Andrew J Krentz; Denise von Mühlen; Elizabeth Barrett-Connor
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

6.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

7.  Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study.

Authors:  Meri-Maija E Ollila; Kari Kaikkonen; Marjo-Riitta Järvelin; Heikki V Huikuri; Juha S Tapanainen; Stephen Franks; Terhi T Piltonen; Laure Morin-Papunen
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

8.  Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome.

Authors:  T M Barber; A J Bennett; C J Groves; U Sovio; A Ruokonen; H Martikainen; A Pouta; A-L Hartikainen; P Elliott; C M Lindgren; R M Freathy; K Koch; W H Ouwehand; F Karpe; G S Conway; J A H Wass; M-R Järvelin; S Franks; M I McCarthy
Journal:  Diabetologia       Date:  2008-05-14       Impact factor: 10.122

9.  Population-based Data at Ages 31 and 46 Show Decreased HRQoL and Life Satisfaction in Women with PCOS Symptoms.

Authors:  Salla Karjula; Laure Morin-Papunen; Stephen Franks; Juha Auvinen; Marjo-Riitta Järvelin; Juha S Tapanainen; Jari Jokelainen; Jouko Miettunen; Terhi T Piltonen
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

10.  Risk of cardiovascular events in mothers of women with polycystic ovary syndrome.

Authors:  Kai I Cheang; John E Nestler; Walter Futterweit
Journal:  Endocr Pract       Date:  2008-12       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.